A postinfluenza model of Staphylococcus aureus pneumonia.

PubWeight™: 2.09‹?› | Rank: Top 2%

🔗 View Article (PMC 3664424)

Published in J Infect Dis on February 15, 2010

Authors

Mei-Ho Lee1, Carlos Arrecubieta, Francis J Martin, Alice Prince, Alain C Borczuk, Franklin D Lowy

Author Affiliations

1: Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

Articles citing this

Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol (2010) 2.14

Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun (2012) 1.70

Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One (2010) 1.64

Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis (2011) 1.56

Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J Immunol (2012) 1.16

Immunopathogenesis of Staphylococcus aureus pulmonary infection. Semin Immunopathol (2011) 1.12

Immune dysfunction and bacterial coinfections following influenza. J Immunol (2013) 1.10

Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol (2011) 1.05

Combined action of influenza virus and Staphylococcus aureus panton-valentine leukocidin provokes severe lung epithelium damage. J Infect Dis (2012) 1.03

Post-influenza pneumonia caused by the USA300 community-associated methicillin-resistant Staphylococcus aureus in Korea. J Korean Med Sci (2012) 1.00

Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection. J Immunol (2014) 0.97

Clinical characteristics and outcomes in hospitalized patients with respiratory viral co-infection during the 2009 H1N1 influenza pandemic. PLoS One (2013) 0.95

Axis of coinfection evil. J Infect Dis (2010) 0.87

Effect of linezolid on clinical severity and pulmonary cytokines in a murine model of influenza A and Staphylococcus aureus coinfection. PLoS One (2013) 0.85

Severe influenza and S. aureus pneumonia: for whom the bell tolls? Virulence (2013) 0.84

Time and dose-dependent risk of pneumococcal pneumonia following influenza: a model for within-host interaction between influenza and Streptococcus pneumoniae. J R Soc Interface (2013) 0.83

Staphylococcus aureus in vitro secretion of alpha toxin (hla) correlates with the affiliation to clonal complexes. PLoS One (2014) 0.83

Community-acquired necrotizing pneumonia due to methicillin-sensitive Staphylococcus aureus secreting Panton-Valentine leukocidin: a review of case reports. Ann Intensive Care (2011) 0.83

Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus Superinfection. MBio (2016) 0.82

The role of respiratory viruses in the etiology of bacterial pneumonia: An ecological perspective. Evol Med Public Health (2016) 0.82

Innate Immune Signaling Activated by MDR Bacteria in the Airway. Physiol Rev (2016) 0.81

Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia. Eur J Immunol (2014) 0.80

Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model. Virulence (2013) 0.80

Molecular characterization of Staphylococcus aureus and influenza virus coinfections in patients with fatal Pneumonia. J Clin Microbiol (2013) 0.79

Upconversion nanoparticles conjugated with curcumin as a photosensitizer to inhibit methicillin-resistant Staphylococcus aureus in lung under near infrared light. Int J Nanomedicine (2014) 0.78

Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease. MBio (2016) 0.78

Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environments. Future Microbiol (2015) 0.77

Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. MBio (2016) 0.77

The role of influenza in the epidemiology of pneumonia. Sci Rep (2015) 0.76

Canine influenza virus coinfection with Staphylococcus pseudintermedius enhances bacterial colonization, virus load and clinical presentation in mice. BMC Vet Res (2016) 0.75

Staphylococcus aureus α-Toxin Response Distinguishes Respiratory Virus-Methicillin-Resistant S. aureus Coinfection in Children. J Infect Dis (2016) 0.75

Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection. Sci Rep (2017) 0.75

Cigarette Smoke Extract-Exposed Methicillin-Resistant Staphylococcus aureus Regulates Leukocyte Function for Pulmonary Persistence. Am J Respir Cell Mol Biol (2016) 0.75

Animal models of polymicrobial pneumonia. Drug Des Devel Ther (2015) 0.75

Secondary Bacterial Infections Associated with Influenza Pandemics. Front Microbiol (2017) 0.75

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis (1999) 19.52

Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA (1998) 15.66

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis (2008) 11.01

Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol (2003) 10.68

The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis (2001) 10.43

Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81

Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis (2006) 8.17

Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep (2009) 8.03

Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science (2007) 7.06

Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet (2006) 6.15

Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis (2004) 6.13

Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med (2007) 5.95

Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev (2006) 5.92

The 1918 influenza pandemic: insights for the 21st century. J Infect Dis (2007) 4.99

Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci U S A (2002) 4.26

Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis (2002) 4.21

Deaths from bacterial pneumonia during 1918-19 influenza pandemic. Emerg Infect Dis (2008) 3.92

Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis (2006) 3.74

Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med (2008) 3.67

Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun (2006) 3.41

Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae. J Infect Dis (2003) 3.12

Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol (1968) 3.04

Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest (2009) 2.96

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79

Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One (2008) 2.62

Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. Lancet (1958) 2.50

Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia. J Infect Dis (2008) 2.41

Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics (2008) 2.29

Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest (2009) 1.77

Leukocidal toxins of staphylococci. Zentralbl Bakteriol (1999) 1.68

IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol (2008) 1.53

Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin? Infect Immun (2009) 1.52

Airway epithelial versus immune cell Stat1 function for innate defense against respiratory viral infection. J Immunol (2008) 1.38

Inhalation of Staphylococcus aureus enterotoxin A induces IFN-gamma and CD8 T cell-dependent airway and interstitial lung pathology in mice. J Immunol (2008) 0.99

Characteristics of Staphylococcus aureus community-acquired pneumonia during the 2006-2007 influenza season. Clin Infect Dis (2007) 0.83

Articles by these authors

Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis (2008) 3.88

Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med (2004) 3.84

Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Am J Gastroenterol (2002) 2.55

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med (2012) 2.46

The clonality of Staphylococcus aureus nasal carriage. J Infect Dis (2005) 2.39

Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem (2004) 2.32

Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol (2006) 2.18

Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2007) 2.13

Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. Am J Respir Cell Mol Biol (2003) 2.09

Innate immunity in the respiratory epithelium. Am J Respir Cell Mol Biol (2011) 2.04

Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med (2012) 2.03

Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. MBio (2012) 2.00

Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol (2003) 2.00

EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest (2014) 1.88

TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration. Cell Host Microbe (2009) 1.87

Staphylococcus aureus ST398, New York City and Dominican Republic. Emerg Infect Dis (2009) 1.83

Revolution in lung cancer: new challenges for the surgical pathologist. Arch Pathol Lab Med (2011) 1.82

Bacterial infections in drug users. N Engl J Med (2005) 1.78

Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A. J Clin Invest (2009) 1.77

Emergence of sequence type 398 as a community- and healthcare-associated methicillin-susceptible staphylococcus aureus in northern Manhattan. Clin Infect Dis (2013) 1.75

Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest (2007) 1.73

TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J Clin Invest (2004) 1.70

Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J Infect Dis (2012) 1.66

Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells. Carcinogenesis (2010) 1.64

Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis (2002) 1.63

Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr Opin Pharmacol (2007) 1.62

Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis (2006) 1.60

The environment as an unrecognized reservoir for community-associated methicillin resistant Staphylococcus aureus USA300: a case-control study. PLoS One (2011) 1.57

Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J Clin Invest (2006) 1.54

Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci U S A (2014) 1.49

The use of a critical care consult team to identify risk for methicillin-resistant Staphylococcus aureus infection and the potential for early intervention: a pilot study. Crit Care Med (2010) 1.47

CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol (2005) 1.47

Future directions of liposome- and immunoliposome-based cancer therapeutics. Semin Oncol (2004) 1.45

VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol (2004) 1.39

Ventricular assist device-related infections. Lancet Infect Dis (2006) 1.37

The NanA neuraminidase of Streptococcus pneumoniae is involved in biofilm formation. Infect Immun (2009) 1.36

Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung. Infect Immun (2002) 1.36

Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio (2011) 1.34

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod Pathol (2012) 1.33

Staphylococcus aureus colonization and the risk of infection in critically ill patients. Infect Control Hosp Epidemiol (2005) 1.32

Staphylococcus aureus oropharyngeal carriage in a prison population. Clin Infect Dis (2011) 1.28

Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother (2012) 1.27

Methicillin-susceptible Staphylococcus aureus ST398, New York and New Jersey, USA. Emerg Infect Dis (2012) 1.23

Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin? Mod Pathol (2007) 1.18

A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol (2010) 1.18

Staphylococcus aureus in the community: colonization versus infection. PLoS One (2009) 1.16

Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J Immunol (2012) 1.16

Emergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speG-mediated adaptations for survival on skin. MBio (2013) 1.15

Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. Am J Respir Cell Mol Biol (2002) 1.15

Participation of CD11c(+) leukocytes in methicillin-resistant Staphylococcus aureus clearance from the lung. Infect Immun (2011) 1.14

Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature. Am J Infect Control (2006) 1.13

Immunopathogenesis of Staphylococcus aureus pulmonary infection. Semin Immunopathol (2011) 1.12

Challenges and strategies for research in prisons. Public Health Nurs (2012) 1.12

Advantages of liposomal delivery systems for anthracyclines. Semin Oncol (2004) 1.12

Computer-aided diagnosis of pulmonary nodules using a two-step approach for feature selection and classifier ensemble construction. Artif Intell Med (2010) 1.12

Staphylococcus aureus protein A mediates invasion across airway epithelial cells through activation of RhoA GTPase signaling and proteolytic activity. J Biol Chem (2011) 1.11

Immunostimulatory properties of the emerging pathogen Stenotrophomonas maltophilia. Infect Immun (2007) 1.11

Staphylococcus aureus CC398 clade associated with human-to-human transmission. Appl Environ Microbiol (2012) 1.10

Activation of Ca2+-dependent signaling by TLR2. J Immunol (2006) 1.09

Pegylated liposomal doxorubicin: proof of principle using preclinical animal models and pharmacokinetic studies. Semin Oncol (2004) 1.08

Epigenetic inactivation of Betaig-h3 gene in human cancer cells. Cancer Res (2006) 1.07

Tgf-beta signaling pathway in lung adenocarcinoma invasion. J Thorac Oncol (2010) 1.07

Secrets of a superbug. Nat Med (2007) 1.07

Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol (2011) 1.05

Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). Int J Antimicrob Agents (2012) 1.05

Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant (2009) 1.05

Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol (2012) 1.05

Prospective, multicenter study of ventricular assist device infections. Circulation (2013) 1.03

Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice. J Infect Dis (2008) 1.03

Effects of azithromycin on clinical isolates of Pseudomonas aeruginosa from cystic fibrosis patients. Chest (2005) 1.03

Airway epithelial cell signaling in response to bacterial pathogens. Pediatr Pulmonol (2008) 1.02

Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets. Arch Pathol Lab Med (2012) 1.02

The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J Infect Dis (2006) 1.01

Expression of syndecan-1 and expression of epidermal growth factor receptor are associated with survival in patients with nonsmall cell lung carcinoma. Cancer (2004) 1.01

Molecular characterization of methicillin-susceptible Staphylococcus aureus clinical isolates in the United States, 2004 to 2010. J Clin Microbiol (2013) 1.01

SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections. PLoS Pathog (2009) 1.00

Histologic assessment of non-small cell lung carcinoma after neoadjuvant therapy. Mod Pathol (2003) 0.99

Cardiac safety of liposomal anthracyclines. Semin Oncol (2004) 0.99

Gene expression profiling of pulmonary fibrosis identifies Twist1 as an antiapoptotic molecular "rectifier" of growth factor signaling. Am J Pathol (2009) 0.98

Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis. Chest (2007) 0.98

Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol (2002) 0.98

Antimicrobial strategies for the prevention and treatment of cardiovascular infections. Curr Opin Pharmacol (2003) 0.97

The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. Am J Respir Cell Mol Biol (2003) 0.96

Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival. Cancer (2010) 0.96

SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. J Biol Chem (2007) 0.96

Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer (2011) 0.96

High prevalence of colonization with Staphylococcus aureus clone USA300 at multiple body sites among sexually transmitted disease clinic patients: an unrecognized reservoir. Microbes Infect (2012) 0.95

Toward an understanding of the evolution of Staphylococcus aureus strain USA300 during colonization in community households. Genome Biol Evol (2012) 0.93

Crystal structures of respiratory pathogen neuraminidases. Biochem Biophys Res Commun (2009) 0.92

Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users. Clin Infect Dis (2007) 0.92

Environmental contamination as a risk factor for intra-household Staphylococcus aureus transmission. PLoS One (2012) 0.92

Pleomorphic (spindle and squamous cell) carcinoma arising in a peripheral mixed squamous and glandular papilloma in a 70-year-old man. Arch Pathol Lab Med (2011) 0.91

Genome Sequence of Bacterial Interference Strain Staphylococcus aureus 502A. Genome Announc (2014) 0.91

Programmed Death Ligand-1 Immunohistochemistry- A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med (2016) 0.91

Role of biofilm in Staphylococcus aureus and Staphylococcus epidermidis ventricular assist device driveline infections. J Thorac Cardiovasc Surg (2010) 0.90

Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration. J Leukoc Biol (2009) 0.89